Prolyl Endopeptidase FAP Solid Tumors clinical trials
7 active Solid Tumors trials that test for Prolyl Endopeptidase FAP in their eligibility criteria. Describe your situation to see which ones look like a fit.
- A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- Lead-212 PSV359 Therapy for Patients With Solid Tumors
- A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Imaging of Solid Tumors Using FAP-2286
- Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.